Abstract:
본 발명은 옻나무 추출물, 이의 분획물 또는 상기 분획물에서 분리한 화합물을 유효성분으로 포함하는 당뇨병 합병증 예방 및 치료용 조성물에 관한 것으로서, 더욱 상세하게는 물, 알코올, 또는 이들의 혼합물을 용매로 하여 추출되는 옻나무 추출물, 이의 분획물 및 상기 분획물에서 분리한 화합물은 당뇨병 합병증의 원인인 소르비톨 축적을 일으키는 알도스 환원효소 억제효과 및 최종당화산물 억제효과를 나타내며, 또한 세포독성이 없는 안정한 물질로 확인되었으므로 당뇨 합병증 예방 및 치료용 조성물로 유용하게 이용될 수 있다.
Abstract:
A food composition comprising the extract of Cutleria cylindrical is provided to improve cancer chemoprevention by inducing activity of quinone reductase as a marker enzyme of cancer prevention and cause no toxicity to human cells. A food composition for cancer chemoprevention comprises 0.001-99.9 wt.% based on the total weight of food, or 0.001-0.1g, preferably 0.05-0.1g in 100 ml of drink of the extract of Cutleria cylindrical which is prepared by extracting Cutleria cylindrical with water or organic solvent such as ethanol, and is formulated as chewing gum, caramel, candy, ice cream, confectionaries, drink, mineral water, alcohol drink, or vitamin- or mineral-containing food.
Abstract:
A method for extraction of leaves of Phyllostachys nigra is provided to prevent destruction of natural antioxidants and improve extraction yield by using high hydrostatic pressure without heat treatment, and inhibit environment pollution by using water as solvent. A method for extraction of leaves of Phyllostachys nigra comprises the steps of: (a) adding water into the dried leaves of Phyllostachys nigra; (b) inserting the water added leaves of Phyllostachys nigra into a high hydrostatic pressure device and treating it under the pressure of 200MPa or more for 1-3 minutes; and (c) leaving the pressure-treated leaves of Phyllostachys nigra at room temperature to extract antioxidants from the leaves of Phyllostachys nigra. A cosmetic composition contains the antioxidants extracted from the leaves of Phyllostachys nigra and is formulated as soap, lotion, cream, pack or solution. Further, a step of hydrating the leaves of Phyllostachys nigra is additionally comprised between the step (a) and the step (b) in the method.
Abstract:
본발명은정향추출물을포함하는대장암표적치료제의항암활성증진용약학적조성물에관한것으로, 보다상세하게는정향추출물및 항암제를포함하는대장암예방또는치료용조성물; 정향추출물을포함하는항암활성증진용식품또는식품첨가물; 및대장암표적치료제및 정향추출물을포함하는조성물을인간을제외한개체에투여하는단계를포함하는대장암치료방법에관한것이다. 본발명에따른조성물은대장암표적치료제와병용할경우, 대장암표적치료제의항암활성을증진시킬수 있다. 따라서, 본발명에따른조성물은항암활성증진용조성물로유용하게사용될수 있다.
Abstract:
본명세서에는신규한용도로사용되는, 더덕추출물을유효성분으로함유하는조성물이개시된다. 일측면에서있어서, 본발명의더덕추출물을유효성분으로함유하는조성물은, 장내유익균의증식을촉진하고, 유해균의증식을억제하고, 장내단쇄지방산의함량을증가시키키며, 장내균총을개선할수 있다. 또한, 본발명의조성물을이용하면, 장건강또는장 기능을개선할수 있으며, 배변기능을개선할수 있다. 또한, 본발명의조성물을프로바이오틱스와병용하면, 프로바이오틱스와의시너지효과를얻을수 있다. 한편, 본발명의더덕추출물을포함하는조성물은, 천연재료를이용하여제조되기때문에, 인체에부작용이없는장점이있다.
koraiensis ) 추출물, 분획물 또는 이로부터 분리한 짐나스테르코리아인 B 화합물을 유효성분으로 함유하는 간 보호용 또는 간 기능 개선용 조성물에 관한 것으로서, 간 손상에 대한 간 보호용 또는 간 기능 개선용 약학적 조성물 또는 식품으로 유용하게 이용될 수 있다.
Abstract:
PURPOSE: A composition containing extract and portions of southernwood wild plants as an active ingredient is provided to activate quinone reductase which is an indicator enzyme for preventing cancer and to activate an antioxidant response element by including extracts and portions of the southernwood wild plants including Adenocaulon himalaicum or Artemisia dubia. CONSTITUTION: A composition for preventing cancers contains extracts and portions of southernwood wild plants including Adenocaulon himalaicum and Artemisia dubia as an active ingredient. The extracts are obtained by extracting dried Adenocaulon himalaicum or Artemisia dubia using alcohol having a carbon number of 1-4 or a mixed solvent. The portions are n-hexane portions, ethylacetate portions, n-butanol portions, or water portions.
Abstract:
An agent for preventing and treating diabetes complication, and a health food are provided to inhibit the activity of the final sugar product and the aldose reductase. An agent for preventing and treating diabetes complication contains an extract of a lacquer tree (Rhus verniciflua) obtained by using water, an alcohol or their mixture as a solvent. Preferably the agent contains further an organic solvent fraction extracted by using an organic solvent. Preferably the organic solvent is n-hexane, methylene chloride, ethyl acetate or n-butanol.
Abstract:
A method for extraction of tectoridin and tectorigenin from the rhizomes of Belamcanda chinensis is provided to reduce the extraction time, improve the extraction yield and enhance environment and human affinity by using only water and ethanol as solvent under high temperature and high pressure. The tectoridin and tectorigenin are extracted from the rhizomes of Belamcanda chinensis through SWE(subcritical water extraction) by heating the rhizomes of Belamcanda chinensis in a mixed solvent containing water and 30-100 vol.% of ethanol to high temperature such as 80 deg. C or more, preferably 80-200 deg. C under high pressure condition such as 1-15 MPa.
Abstract:
A pharmaceutical composition comprising the extract of Cutleria cylindrical is provided to induce activity of quinone reductase, lead no an activity of phase 1 detoxification enzyme system but an activity of phase 2 detoxification enzyme system, inhibit cytotoxicity, and suppress increase carcinogenic and procarcinogenic materials and promote their release. A pharmaceutical composition for cancer chemoprevention comprises 0.001-99.9 wt.% of the extract of Cutleria cylindrical which is prepared by washing Cutleria cylindrical collected with water to remove foreign substances and salt, drying the Cutleria cylindrical, extracting the dried Cutleria cylindrical with solvent, preferably ethanol, filtering the extract of Cutleria cylindrical, and vacuum-concentrating and drying the filtered Cutleria cylindrical extract, and is formulated as powder, granule, tablet, capsule, suspension, emulsion, syrup, aerosol, ointment, cream, suppository or sterile injection solution, wherein the daily dosage of the Cutleria cylindrical extract is 0.001-1000 mg/kg.